Insurer's approval of genetic testing for some cancers raises questions
from USA Today
Pennsylvania-based Independence Blue Cross’ announcement that it will cover a complex type of genetic testing for some cancer patients thrusts the insurer into an ongoing debate about how to handle an increasing array of these expensive tests. Independence – with its approximately 3 million members – became the largest insurer to cover whole-genome sequencing for select cancer patients.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063